- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/31 - Chimeric antigen receptors [CAR]
Patent holdings for IPC class A61K 40/31
Total number of patents in this class: 1965
10-year publication summary
|
0
|
1
|
6
|
24
|
85
|
110
|
62
|
45
|
761
|
233
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4406 |
69 |
| The Regents of the University of California | 20494 |
49 |
| Kite Pharma, Inc. | 430 |
42 |
| Memorial Sloan-Kettering Cancer Center | 2007 |
36 |
| Juno Therapeutics, Inc. | 485 |
34 |
| City of Hope | 1016 |
33 |
| Board of Regents, The University of Texas System | 6037 |
32 |
| Janssen Biotech, Inc. | 1657 |
29 |
| The Board of Trustees of the Leland Stanford Junior University | 6604 |
28 |
| Novartis AG | 10450 |
26 |
| Allogene Therapeutics, Inc. | 158 |
26 |
| Autolus Limited | 265 |
24 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1006 |
21 |
| Immunitybio, Inc. | 492 |
21 |
| The General Hospital Corporation | 4809 |
19 |
| Dana-Farber Cancer Institute, Inc. | 2635 |
18 |
| Sloan-Kettering Institute for Cancer Research | 574 |
18 |
| Memorial Hospital for Cancer and Allied Diseases | 356 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4569 |
17 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2966 |
17 |
| Other owners | 1388 |